These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15235190)

  • 1. Bednar tumor: a report of two cases.
    Yagi Y; Ueda K; Maruyama S; Noborio R
    J Dermatol; 2004 Jun; 31(6):484-7. PubMed ID: 15235190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of pigmented dermatofibrosarcoma protuberans (Bednar tumor).
    Akasaka T; Ohyama N; Kon S
    J Dermatol; 1997 Jun; 24(6):390-4. PubMed ID: 9241967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bednar tumor (pigmented dermatofibrosarcoma protuberans) occurring in a site of prior immunization: immunochemical findings and therapy.
    Elgart GW; Hanly A; Busso M; Spencer JM
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):315-7. PubMed ID: 10025857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.
    Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M
    Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerosing Dermatofibrosarcoma Protuberans Shows Significant Overlap With Sclerotic Fibroma in Both Routine and Immunohistochemical Analysis: A Potential Diagnostic Pitfall.
    Abdaljaleel MY; North JP
    Am J Dermatopathol; 2017 Feb; 39(2):83-88. PubMed ID: 28134725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
    Horenstein MG; Prieto VG; Nuckols JD; Burchette JL; Shea CR
    Am J Surg Pathol; 2000 Jul; 24(7):996-1003. PubMed ID: 10895822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+ pigmented fibrous proliferations: the morphologic overlap between pigmented dermatofibromas and Bednar tumors.
    McAllister JC; Recht B; Hoffman TE; Sundram UN
    Am J Dermatopathol; 2008 Oct; 30(5):484-7. PubMed ID: 18806495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myxoid dermatofibroma on a great toe: a case report.
    Moon A; Yoon N; Kim HS
    Int J Clin Exp Pathol; 2015; 8(6):7605-9. PubMed ID: 26261677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma.
    Lazova R; Moynes R; May D; Scott G
    Cancer; 1997 Jun; 79(11):2115-24. PubMed ID: 9179057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34-reactive myxoid dermal dendrocytoma.
    Ohata C; Kawahara K
    Am J Dermatopathol; 2002 Feb; 24(1):50-3. PubMed ID: 11803282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of Bednar tumor. Immunohistochemical positivity for CD34.
    Kobayashi T; Hasegawa Y; Konohana A; Nakamura N
    Dermatology; 1997; 195(1):57-9. PubMed ID: 9267742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It's a dermatofibroma, CD34 is irrelevant!
    Zelger B
    Am J Dermatopathol; 2002 Oct; 24(5):453-4. PubMed ID: 12357213
    [No Abstract]   [Full Text] [Related]  

  • 13. A 42-year-old woman with an abdominal mass. Dermatofibrosarcoma protuberans with focal fibrosarcomatous transformation.
    Al-Agha OM; Tabassum F
    Arch Pathol Lab Med; 2006 Jun; 130(6):882-5. PubMed ID: 16740047
    [No Abstract]   [Full Text] [Related]  

  • 14. The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.
    Sadullahoğlu C; Dere Y; Atasever TR; Öztop MT; Karaaslan Ö
    Turk Patoloji Derg; 2017; 1(1):223-227. PubMed ID: 28832078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
    Goldblum JR; Tuthill RJ
    Am J Dermatopathol; 1997 Apr; 19(2):147-53. PubMed ID: 9129699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
    Bandarchi B; Ma L; Marginean C; Hafezi S; Zubovits J; Rasty G
    Mod Pathol; 2010 Mar; 23(3):434-8. PubMed ID: 20062007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans.
    Zelger BW; Ofner D; Zelger BG
    Histopathology; 1995 Jun; 26(6):519-27. PubMed ID: 7545142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A firm red-brown plaque on the arm. Dermatofibrosarcoma protuberans(DFSP), pigmented variant (Bednar tumor.
    Quigley EA; Marghoob AA; Busam KJ; Chen CS
    Arch Dermatol; 2009 May; 145(5):589-94. PubMed ID: 19451510
    [No Abstract]   [Full Text] [Related]  

  • 19. Pigmented dermatofibrosarcoma protuberans with prominent meningothelial-like whorls.
    Wang J; Yang W
    J Cutan Pathol; 2008 Oct; 35 Suppl 1():65-9. PubMed ID: 18544057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When Immunohistochemistry Deceives Us: The Pitfalls of CD34 and Factor XIIIa Stains in Dermatofibroma and Dermatofibrosarcoma Protuberans.
    John AM; Holahan HH; Singh P; Handler MZ; Lambert WC
    Skinmed; 2017; 15(1):53-55. PubMed ID: 28270311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.